The multiple is a mirage until the new business reports
Uranium Royalty screens cheap, and we think the screen is measuring a business that no longer exists. At $4.67 on Thursday, September 10, the stock trades at 10.0x trailing earnings, below its peer median of 13.7x and far below its own two-year median of 24.3x [1]. The problem is what those earnings were made of.
For the fiscal year ended April 30, 2026, selling uranium inventory generated $186.8 million of revenue while royalty revenue was $0.15 million [2]. Net income of $40.2 million was almost entirely inventory realization, and the remaining 593,255 pounds were sold after year-end at $85.91 per pound for $51.0 million, so the inventory that produced the earnings is gone [3]. The company then combined with Sweetwater on July 27, 2026, issuing 223,252,749 shares at a deemed $3.64 and paying $330 million cash, and it inherited $688.8 million of 5.32% notes due 2040 plus a $40.0 million facility drawn as of July 28 [4]. Our read: this is now a soda-ash royalty and land company with a much larger share count and real debt service, and no combined-period results exist yet to value it on.
The tape has run ahead of that proof. The stock is up 54.1% over the last 60 trading days and sits 14.5% below its January 28 closing high, while eight in ten closes since March 20 were between $2.78 and $4.24 [5]. Wednesday's volume was 23% of its 20-day average, and short interest was 3.21% of the float at the August 14 settlement [6]. Our book does not hold UROY. Our open hypothesis on this name, sealed September 4 with low belief, is a watch at $4.19; that entry sits at the top of the band where most of this year's trading happened, and we set it there rather than at today's extended price [7]. The company was on the earnings calendar for Wednesday with the street looking for $0.05 in EPS, so the first combined-period numbers are the test [8]. On our record so far, this cohort carries 3 machine-tracked calls, 1 open and 2 not yet due, none scored; that is provisional and not a finalized accuracy claim.
We stay on watch. What proves us wrong: the first reported combined period shows royalty revenue arriving at scale while the stock holds above $4.19, meaning the platform worked and waiting on price was the mistake. We come back to this by January 31, 2027, or at the combined-period report if it lands first.
The call
Stance: watch
Level: 4.19
Horizon: 2027-01-31
Checkpoint: 2027-01-31
What closes the file: The first reported combined period shows royalty revenue arriving at scale while the stock holds above $4.19, meaning the platform proved out and the wait on price was the mistake.
Receipts8
[1] Market context, 2026-09-10: UROY closed $4.67; trailing P/E 10.0x vs peer median 13.7x and own two-year median 24.3x (FMP profile/key-metrics, fetched 2026-09-10).
[2] 10-K filed 2026-07-28, accession 0001193125-26-321135, Item 7 Selected 2026 Highlights and Item 1 Operational Information: $186.8M revenue from sale of uranium inventory; uranium royalty revenue $0.15M, year ended April 30, 2026. https://www.sec.gov/Archives/edgar/data/2143673/000119312526321135/uroy-20260430.htm
[3] Same 10-K, Item 7 Overall Performance and Physical Uranium: net income $40.2M; subsequent sale of 593,255 lb at $85.91/lb for $51.0M.
[4] Same 10-K, Item 1 Development of the Business, Senior Secured Notes, Credit Facility: 223,252,749 shares at deemed $3.64; $330M cash; $688,778,929 of 5.32% notes due September 30, 2040; $40.0M drawn as of July 28, 2026.
[5] Market context, 2026-09-10: +54.1% over 60 trading days; 14.5% below the $5.46 closing high of 2026-01-28; 96 of 120 closes since 2026-03-20 between $2.78 and $4.24.
[6] Trading activity, 2026-09-10: 572,949 shares traded against a 2.45 million 20-day average; short interest 4.02 million shares, 3.21% of float, at the 2026-08-14 settlement.
[7] Open hypothesis hyp-UROY-d71428509b77, sealed 2026-09-04: watch, level $4.19, checkpoint 2027-01-31, low belief.
[8] Earnings calendar: UROY reporting 2026-09-10, street estimate $0.05 EPS.
